Business Terms
Accelerate Diagnostics Submits Wave Platform, Gram-Negative Test to FDA
The company also reported that its fourth quarter revenues dropped 7 percent from a year ago, while its full-year 2024 revenues declined 3 percent.
Kiffik Biomedical, Rubix LS Partner on Colorectal Cancer Test Development
The New England-based firms said that they are developing a rapid at-home test that will be used to detect cancer biomarkers in interstitial fluid samples.
In Brief This Week: Quest Diagnostics; Revvity; Enzo Biochem; 4baseCare; Circular Genomics
News items for the week of March 17, 2025.
The test can be used to better stratify cancer patients and determine the likelihood of breast cancer metastasizing.
Public health labs have handled most testing thus far for the Texas and New Mexico outbreaks, but commercial labs are beginning to bring molecular measles assays online.